“5-Azacytidine Treatment Inhibits the Development of Lung Cancer Models via Epigenetic Reprogramming and Activation of Cellular Pathways With Anti-Tumor Activity”. 2024. Medicine and Pharmacy Reports 97 (4): 488-506. https://doi.org/10.15386/mpr-2777.